Yesterday we saw Integra LifeSciences (IART) fall 4.18% alongside the market. Both European and emerging-market stocks are facing an especially dismal start to 2014. Emerging-markets alone have decreased 8.5% this year, which is the most it has in over twenty years. This puts Integra at risk, being that approximately 23% of their total revenue is international and 12% of that European. Today the stock bounced back .63%, closing at a price of $44.80.